X-Gen Ventures

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

At XGEN we specialize in early stage investments in private research & development companies in the life sciences sector.

Venture capitalMilan, Italyxgenventure.comSince 2023-11-14

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$72.4M

across 1 round

LATEST ROUND

Series C · $72.4M · 2023-11-14

CO-INVESTORS

named beside it

Investor

The rounds this investor is named on, who it invests beside, and where it shows up.

Nouscom[ PART ]

Nouscom is a biotech company selling cancer-preventing vaccine candidates primarily to healthcare providers and clinical trial organizations.

Series C$72.4M2023-11-141 [ HISTORY ]

Company	Round	Amount	Announced	Role
Nouscom Nouscom is a biotech company selling cancer-preventing vaccine candidates primarily to healthcare providers and clinical trial organizations.	Series C Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$72.4M	2023-11-14	[ PART ]